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In This IssueTwo scientists walk into a bar. After a pint and an exchange of pleasantries, one says to the other, ‘‘Where
do you come from? Scientifically, I mean.’’ The queried scientist responds, ‘‘Out of the RNA world.’’ ‘‘Don’t
we all,’’ the asker responds chuckling. Fifteen years ago, the joke would have been made with a nod to the
notion that life arose from an RNA-based precursor, the so-called ‘‘RNA world.’’ Yet had this conversation
happened last week, the scientists would also be grinning in appreciation of the extent to which contem-
porary cellular biology is steeped in all things RNA. Ours is truly an RNA world.
In this year’s special review issue, the Cell editorial team has brought together articles focused on RNA
in the modern world, providing perspectives on classical and emerging areas of inquiry. We extend our
thanks to the many distinguished experts who contributed their time and effort as authors and reviewers
to make the issue informative, thought-provoking, and timely. We hope that this collection of articles,
written as we stand on the verge of a new wave of RNA biology, edifies and inspires by revealing the inner
workings of these versatile molecules and by highlighting the next key questions that need to be
addressed as we strive to understand the full functional scope of RNA in cells.
RNA’s Evolutionary Road
In his introductory Essay (page 577), Phillip Sharp sets the stage for this RNA special review issue by taking us on a time-traveler’s
tour of the RNA world, looking back at some of the earliest discoveries about the roles of RNA in biological processes and discussing
how these early findings may help us to anticipate future discoveries about these mole-
cules that drive biology.
Not only is it an RNA world, but it is also an RNP (ribonucleoprotein) world as Thomas
Cech notes in his Essay on page 599. This Essay moves beyond considering a simple
sequential line of evolution from RNA-based to protein-based life and argues that
RNPs are evolving in lock-step with proteins, allowing cells to capitalize on the attributes
of both biopolymers. One such RNP, the spliceosome, is a large, dynamic assemblage of
proteins and RNAs that occupies a central and essential position in the mRNA produc-
tion pipeline. The Review by Markus Wahl, Cindy Will, and Reinhard Lu¨hrmann (page
701) examines the spliceosome and seeks to discern the underlying design principles
for this complex machine. The authors explore the factors and regulatory steps that
remodel the spliceosome during splicing. In the broadest sense, each mRNA provides
the scaffold for an immense RNP built during transcription, pre-mRNA splicing, and
nuclear export. Megan Bergkessel, Gwendolyn Wilmes, and Christine Guthrie (SnapShot,
page 794) provide a visual illustration of the path to orchestrated assembly of cytoplasm-
bound mRNPs.
Knowing When to Hold ’em and When to Fold ’em
Fidelity is a central concern in bringing information out of DNA and implementing it. Accurate production of mature mRNAs from initial
gene transcripts is a highly complex and dynamic process. The Review by Melissa Moore and Nicholas Proudfoot (page 688)
dissects how pre-mRNA processing contributes to both the overall efficiency and fidelity of gene expression and emphasizes
how processing impacts both upstream and downstream events. However, not every custom-made RNA is fit to be translated,
as Jonathan Houseley and David Tollervey point out (Review, page 763). These authors present the various and often partially redun-
dant RNA degradation pathways that eliminate RNAs with defects in processing, folding, or protein association and consider the
mechanisms by which these processes protect cells from aberrant transcripts. For mRNAs passing these quality controls, the trans-
lation machinery then imposes high standards of fidelity in protein synthesis. Hani Zaher and Rachel Green (Review, page 746)
summarize advances in our understanding of how the ultimate RNA enzyme, the ribosome, instigates checks and balances to ensure
the accurate translation of mRNAs into proteins. Beyond accuracy, translation itself is a highly regulated process tying protein
synthesis to the needs of a cell. Nahum Sonenberg and Alan Hinnebusch (Review, page 731) present an overview of translational
regulation at the step of translation initiation. The authors place these regulatory mechanisms in a biological context by considering
embryogenesis in the fruit fly and neuronal synaptic plasticity and disease in mammals.
Getting in Shape and Going on Location
For RNAs, as with proteins, form and function go hand in hand. Jose´ Almeida Cruz and Eric Westhof (Essay, page 604) discuss the
determinants of RNA architecture and explore how different types of interactions (e.g., secondary versus tertiary contacts) establish
hierarchies in the RNA folding process. Having the right shape is important, but the old adage about real estate holds for RNA as well.
In many cases, function depends on location, location, location. Taking as a starting point the emerging realization that a large
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fraction of mRNAs are localized to distinct cytoplasmic compartments, Kelsey Martin and Anne Ephrussi (Review, page 719) view
mRNA localization as an extension of gene expression into the spatial dimension. They describe how cis-acting RNA localization
elements, recruitment of trans-acting factors, and transport of RNA granules to their final destinations in the cell promote facets
of development and neuronal function.
In Sickness and in Health
Findings from labs engaged in both basic and translational research as well as from genomics and bioinformatics studies have deep-
ened our appreciation of the integral roles that RNAs, and the pathways and processes that shape them, play in maintaining the
health of organisms. Compromised RNA lies at the center of many human diseases as discussed by Thomas Cooper, Lili Wan,
and Gideon Dreyfuss (Review, page 777). Using examples of pathologies caused by aberrant splicing, these authors explore the
discovery of new disease-causing mutations in RNAs and the therapeutic targets they yield. Moreover, it is becoming apparent
that when tiny RNAs called microRNAs (miRNAs) go awry, the consequences can be dire. MicroRNA malfunction presages tumor
formation and progression through a variety of oncogenic mechanisms (Essay by Andrea Ventura and Tyler Jacks, page 586). In
an Analysis article (page 581), Laura Bonetta offers up the flip side of RNAs and disease as she highlights progress in developing
RNA-based therapeutics, a few of which are already in clinical trials. Although it is early days, the sheer diversity of RNAs and
RNA-based mechanisms to exploit for therapeutic benefit provides great opportunity. The magnitude of the opportunity is matched
by the challenge of targeted delivery strategies for these potential drugs.
Studying at the Feet of Microbial Masters
For all that we have learned about RNA biology from studying eukaryotes, other organisms have had, and continue to have, plenty of
lessons to teach us. Bacteria use RNAs in a wide spectrum of functional and regulatory processes. Lauren Waters and Gisela Storz
(Review, page 615) examine the ways that bacteria modulate gene expression using a variety of unusual RNAs and make the case
that these RNAs are an ideal system with which to elucidate mechanistic questions about regulatory RNAs in eukaryotes. Continuing
in this vein, Bryan Cullen (Essay, page 592) explores the many ways in which viral RNAs have provided unexpected insights into the
nuts and bolts of fundamental host cell processes.
The Long and the Short of Genome Regulation
The functional potential of RNAs expands every time a new class of RNA is discovered. With the identification of stable small RNAs,
the era of regulatory RNAs, particularly in higher eukaryotes, has accelerated with astounding speed. Richard Carthew and Erik
Sontheimer (Review, page 642) update us on two kinds of small regulatory RNAs, miRNAs and short-interfering RNAs (siRNAs),
and discuss the molecular players and mechanisms involved in their biogenesis and their effector functions. Olivier Voinnet
(Review, page 669) takes us on a brief excursion away from metazoans to learn about the regulation and functions of miRNAs
in plants. This author highlights the similarities between the plant miRNA system and its metazoan counterpart and proposes
that, in plants, miRNAs may be more similar than previously appreciated to the siRNAs that mediate gene silencing. Turning to
other responsibilities of small cellular RNAs, Colin Malone and Gregory Hannon (Review,
page 656) explicate the roles played by small RNAs in safeguarding genome integrity
from rampant transposon migration. This strategy for controlling transposons is remark-
ably conserved in a variety of organisms.
The cumulative work on small regulatory RNAs casts a long shadow. However, long
noncoding RNAs are starting to emerge from this shadow to take their place in the lime-
light. As Chris Ponting, Peter Oliver, and Wolf Reik (Review, page 629) point out, long
noncoding RNAs, conventionally thought to be an accident of transcription, are not just
‘‘transcriptional noise’’ but rather may turn out to be important players in transcriptional
regulation, epigenetic regulation, and disease. Long and short RNAs can sometimes
collaborate, as illustrated by Hugh Cam, Ee Sin Chen, and Shiv Grewal (Essay, page
610), who emphasize that the primary products of transcription, as well as the small
RNA molecules that result from processing these long RNAs, can serve as scaffolds for
heterochromatin assembly.
A Toast to the Future
At meetings, at journal clubs, in casual conversations at the bar, RNAs and their myriad roles are the center of attention. We are
excited to bring to our readers an issue devoted to this fascinating biopolymer, and we look forward to what lies ahead.
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